2018
DOI: 10.1111/1756-185x.13296
|View full text |Cite
|
Sign up to set email alerts
|

Erasmus syndrome: systemic sclerosis and silicosis co‐occurrence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 17 publications
0
1
0
Order By: Relevance
“…The treatment of ES is no different to that for idiopathic forms of SSc. Case reports of ES describe the use of methylprednisolone, mycophenate, azathioprine, cyclophosphamide, acetylsalicylic acid, methotrexate, endothelin receptor antagonists, amlodipine, and nifedipine for treatment ( 20 - 23 ). In our case, after diagnosis, the patient was treated with methylprednisolone.…”
Section: Discussionmentioning
confidence: 99%
“…The treatment of ES is no different to that for idiopathic forms of SSc. Case reports of ES describe the use of methylprednisolone, mycophenate, azathioprine, cyclophosphamide, acetylsalicylic acid, methotrexate, endothelin receptor antagonists, amlodipine, and nifedipine for treatment ( 20 - 23 ). In our case, after diagnosis, the patient was treated with methylprednisolone.…”
Section: Discussionmentioning
confidence: 99%
“…Parenteral cyclophosphamide, mycophenolate mofetil, and azathioprine and the combination of these two agents with systemic steroids are among the most frequently used agents in interstitial lung disease. [ 9 10 ]…”
Section: Discussionmentioning
confidence: 99%